These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24625231)

  • 21. Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor.
    Ogiyama T; Yamaguchi M; Kurikawa N; Honzumi S; Terayama K; Nagaoka N; Yamamoto Y; Kimura T; Sugiyama D; Inoue SI
    Bioorg Med Chem; 2017 Sep; 25(17):4817-4828. PubMed ID: 28756012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new esterase, belonging to hormone-sensitive lipase family, cloned from Rheinheimera sp. isolated from industrial effluent.
    Virk AP; Sharma P; Capalash N
    J Microbiol Biotechnol; 2011 Jul; 21(7):667-74. PubMed ID: 21791951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential inhibitors for AIRS from de novo purine biosynthesis pathway through molecular modeling studies - a computational approach.
    Rao RG; Biswal J; Dhamodharan P; Kanagarajan S; Jeyaraman J
    J Biomol Struct Dyn; 2016 Oct; 34(10):2199-213. PubMed ID: 26524231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective virtual screening strategy toward covalent ligands: identification of novel NEDD8-activating enzyme inhibitors.
    Zhang S; Tan J; Lai Z; Li Y; Pang J; Xiao J; Huang Z; Zhang Y; Ji H; Lai Y
    J Chem Inf Model; 2014 Jun; 54(6):1785-97. PubMed ID: 24857708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Evaluation of Inhibitors of Lipase from
    Ali S; Khan FI; Mohammad T; Lan D; Hassan MI; Wang Y
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship for aryl and heteroaryl boronic acid inhibitors of hormone-sensitive lipase.
    Ebdrup S; Jacobsen P; Farrington AD; Vedsø P
    Bioorg Med Chem; 2005 Mar; 13(6):2305-12. PubMed ID: 15727879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism-based inhibitors of mammalian cholesterol esterase.
    Feaster SR; Quinn DM
    Methods Enzymol; 1997; 286():231-52. PubMed ID: 9309653
    [No Abstract]   [Full Text] [Related]  

  • 31. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbazates as potent inhibitors of hormone-sensitive lipase.
    de Jong JC; Sørensen LG; Tornqvist H; Jacobsen P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1741-4. PubMed ID: 15026062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors.
    Miguet L; Zhang Z; Barbier M; Grigorov MG
    J Comput Aided Mol Des; 2006 Feb; 20(2):67-81. PubMed ID: 16783599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore based virtual screening, synthesis and SAR of novel inhibitors of Mycobacterium sulfotransferase.
    Saha R; Tanwar O; Alam MM; Zaman MS; Khan SA; Akhter M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):701-7. PubMed ID: 25541388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.
    Zhou C; Kang D; Xu Y; Zhang L; Zha X
    Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase.
    Lowe DB; Magnuson S; Qi N; Campbell AM; Cook J; Hong Z; Wang M; Rodriguez M; Achebe F; Kluender H; Wong WC; Bullock WH; Salhanick AI; Witman-Jones T; Bowling ME; Keiper C; Clairmont KB
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3155-9. PubMed ID: 15149665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
    Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
    J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
    Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.